VOLIFIL SUB Q - 1x1.1 ml with Lidocaine – Deep Volumizing Filler for Structural Contouring
VOLIFIL SUB Q 1x1.1 ml with Lidocaine is an ultra-dense hyaluronic acid dermal filler developed by BNC KOREA, Inc. for deep tissue augmentation and structural facial contouring.
As the thickest and most cohesive filler in the VOLIFIL line, it delivers strong lifting capacity, durable volume restoration, and defined facial contours with natural integration.
The inclusion of lidocaine (0.3%) ensures maximum patient comfort during injection.
Product Overview
VOLIFIL SUB Q is designed for areas that require deep structural support, including the jawline, chin, cheeks, and nose.
Its high cross-linking density and HCCL™ Technology provide outstanding elasticity and lift while maintaining a smooth, uniform texture that integrates seamlessly with tissue.
Composition & Technology
Active Ingredients:
Cross-linked Hyaluronic Acid (HA): 20 mg/ml
Lidocaine Hydrochloride: 0.3%
Technology:
HCCL™ Technology (High Concentration Cross-Linking):
A proprietary BNC KOREA process that ensures exceptional gel homogeneity, elasticity, and resistance to degradation. This technology enhances the filler’s longevity, cohesiveness, and lifting strength for optimal sculpting precision.
Mechanism of Action:
Restores deep volume loss
Reconstructs contours in subcutaneous layers
Lifts and defines the jawline, cheeks, chin, and nose
Packaging
1 x 1.1 ml prefilled syringe
2 sterile needles
Product labels
Professional user instructions
Indications & Treatment Areas
Deep Wrinkle & Fold Correction: Nasolabial folds, marionette lines
Facial Volume Restoration: Chin, cheeks, temples, and jawline
Non-Surgical Contouring: Nose bridge definition, facial reshaping
Clinical Benefits
High Viscosity & Lift: Designed for deep volumization and contour stability
Superior Durability: Results last 9–12 months, depending on area and technique
Natural Integration: Smooth monophasic gel structure ensures seamless results
Comfortable Application: Contains lidocaine for reduced pain during injection
Treatment Protocol
Injection Depth: Deep dermis or subcutaneous layer
Technique: Linear retrograde or bolus injection depending on the area treated
Post-Treatment Care: Avoid heat exposure, sun, or physical exertion for 24–48 hours.
Manufacturer & Regulatory Information
Manufacturer: BNC KOREA, Inc. (South Korea)
Compliance:
• CE-marked Class III Medical Device under EU Regulation (MDR) 2017/745
• ISO 13485 certified manufacturer
• Distributed under compliance with AEMPS (Agencia Española de Medicamentos y Productos Sanitarios) in Spain and the European Union
For Professional Use Only:
As trusted distributors and providers of aesthetic medicine, Aesthisave® emphasizes that our products are strictly for professional use.
We insist that these treatments be administered only by trained and medically qualified personnel, ensuring the highest standards of safety, precision, and patient care.
